4//SEC Filing
Brown Victoria L. 4
Accession 0001127602-21-011597
CIK 0001492422other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:58 PM ET
Size
7.0 KB
Accession
0001127602-21-011597
Insider Transaction Report
Form 4
Brown Victoria L.
Program Team Lead
Transactions
- Award
Common Stock
2021-03-01+1,250→ 10,034 total - Award
Stock Option (Right to Buy)
2021-03-01+7,500→ 7,500 totalExercise: $47.68Exp: 2031-02-28→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]This Performance Unit grant will vest 25% annually over four years from grant date, subject to the satisfaction of a specified performance condition and continued service.
- [F2]This stock option will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to the satisfaction of a specified performance condition and continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001810475
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 5:58 PM ET
- Size
- 7.0 KB